Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients

Summary

Aim: To assess the effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients free of arterial hypertension and diabetes mellitus.

Methods and Results: The study included 36 patients (25 men and 11 women, mean age 56?±?12 years); 18 patients had stable coronary heart disease (CHD) and 18 were free of CHD at baseline. All patients received atorvastatin (20mg/day) for a 2-year period. Aortic stiffness was assessed by transthoracic echocardiography at baseline and 2 years later. At baseline, total cholesterol, low density lipoprotein cholesterol (LDL-C) and LDL-C/high density lipoprotein cholesterol (HDL-C) ratio were positively related to aortic stiffness (p?p?=?0.029 to <0.0001). After the 2-year treatment with atorvastatin, aortic stiffness was significantly reduced by 14% (p?=?0.019). An improvement of left ventricular (LV) ejection fraction by 13% (p?p?=?0.008) were also recorded. The change in aortic stiffness was similar in patients with or without CHD.

Conclusion: Long-term treatment with atorvastatin improves aortic stiffness; this index is related to total and coronary mortality. Moreover, assessment of aortic stiffness may be useful in identifying which hypercholesterolaemic patients should be treated aggressively, regardless of CHD. The aortic stiffness effect may eventually become an index of the efficacy of lipid lowering treatment.